Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Angela Toro"'
Autor:
Stephen M. Ansell, Thomas M. Habermann, Joseph R. Mikhael, Patrick B. Johnston, Leslie Padrnos, Grzegorz S. Nowakowski, Brenda Ginos, Brenda Ernst, Craig B. Reeder, Amylou C. Dueck, Joseph P. Colgan, Luis F. Porrata, Angela Toro, Jose F. Leis, Heidi E. Kosiorek, Thomas E. Witzig
Publikováno v:
Clinical lymphoma, myelomaleukemia. 18(10)
Background Treatment outcomes have improved in lymphoid malignancies but relapse remains inevitable for most patients. Everolimus and lenalidomide have shown clinical activity as single agents in patients with relapsed and refractory Hodgkin and non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66da81caab10ce2e0d90e605872e56f3
https://pubmed.ncbi.nlm.nih.gov/30104176
https://pubmed.ncbi.nlm.nih.gov/30104176
Autor:
Brenda Ernst, Amylou Constance Dueck, Angela Toro, Patrick B. Johnston, Thomas Haberman, Jose F. Leis, Joseph R. Mikhael, Grzegorz S. Nowakowski, Joseph P. Colgan, Luis F. Porrata, James L Slack, Stephen M. Ansell, Thomas E. Witzig, Craig B. Reeder
Publikováno v:
Blood. 124:3100-3100
Introduction New treatment strategies are improving outcomes for patients with Hodgkin (HL) and non-Hodgkin lymphoma (NHL) but achieving durable responses and cure in the relapsed patient remain a challenge. Both the mTORC1 inhibitor everolimus (RAD0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf6fceae95e8a8dd9d9720331ddc9d59
https://doi.org/10.1182/blood.v124.21.3100.3100
https://doi.org/10.1182/blood.v124.21.3100.3100
Autor:
Allison C. Rosenthal, Craig B. Reeder, Amylou C. Dueck, Thomas M. Habermann, Angela Toro, Sravan K. Nagi Reddy, Patrick B. Johnston, Craig Nichols, Donald W. Northfelt, Jose F. Leis, Thomas E. Witzig, Daniel J. Johnson, Katherine Gano, James L. Slack, P. Leif Bergsagel, Rodger E. Tiedemann
Publikováno v:
Blood. 124:4410-4410
Introduction Non-Hodgkin lymphoma responds to single agents such as cyclophosphamide, combination therapy such as CVP and immunotherapy with monoclonal antibodies such as rituximab. There is no consensus on the optimal treatment for relapsed low grad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89d0bddb73462bba9fa479f4600c0adf
https://doi.org/10.1182/blood.v124.21.4410.4410
https://doi.org/10.1182/blood.v124.21.4410.4410
Autor:
Patrick B. Johnston, Craig B. Reeder, Joseph R. Mikhael, Jose F. Leis, Angela Toro, Grzegorz S. Nowakowski, James L. Slack, Daniel J. Johnson, Thomas M. Habermann, Luis F. Porrata, Joseph P. Colgan, Amylou C. Dueck, Katherine Gano, Stephen M. Ansell, Craig Nichols, Thomas E. Witzig
Publikováno v:
Blood. 122:4350-4350
Introduction Outcomes have improved in treating lymphoid malignancies but relapse remains an ongoing issue. The mTOR inhibitor, everolimus (RAD) and lenalidomide (LEN) have both shown clinically significant activity as single agents in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afebf7c107c87cfb2b3eda480fd0bc98
https://doi.org/10.1182/blood.v122.21.4350.4350
https://doi.org/10.1182/blood.v122.21.4350.4350
Autor:
Jeffrey Betcher, Ruben A. Mesa, Pierre Noel, Craig B. Reeder, Jared Klein, Meagan S. Higgins, Lisa Sproat, Lori DeCook, Roberta H. Adams, Veena Fauble, Jose F. Leis, Kimberly J. Henderson, Angela Toro, Yu-hui Chang, Nandita Khera, Jane Palmer, Kristen Beebe, James L. Slack, Rochelle Chiffelle, Susan Gerber, Jane Olsen
Publikováno v:
Blood. 122:2835-2835
Introduction Myelofibrosis (MF), both primary myelofibrosis (PMF) and post essential thrombocytosis/polycythemia vera myelofibrosis (post ET/PV-MF), are chronic myeloproliferative neoplasms that are incurable with standard medical therapy. The only p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e148b8fbd802217a8eea90b44196504
https://doi.org/10.1182/blood.v122.21.2835.2835
https://doi.org/10.1182/blood.v122.21.2835.2835
Autor:
Craig B. Reeder, Lisa Sproat, Roberta H. Adams, Angela Toro, James L. Slack, Rochelle Chiffelle, Pierre Noel, Jane Palmer, Brooke Loewen, Susan Gerber, Jane Olsen, Veena Fauble, Kristen Beebe, Jose F. Leis, Nandita Khera
Publikováno v:
Blood. 120:1954-1954
Abstract 1954 Introduction: Vitamin D (VD) deficiency can cause osteomalacia, aching bone pain, muscle weakness, fatigue, increase risk of fracture and precipitate or exacerbate osteopenia/osteoporosis. Allogeneic hematopoietic stem cell transplant (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaf8e3a62e9df435017c9af6d3ca4d69
https://doi.org/10.1182/blood.v120.21.1954.1954
https://doi.org/10.1182/blood.v120.21.1954.1954
Autor:
Jose F. Leis, Roberta H. Adams, Nandita Khera, Craig B. Reeder, Jane Palmer, Raoul Tibes, Susan Gerber, Pierre Noel, Angela Toro, Brooke Loewen, Lisa Sproat, Ruben A. Mesa, Jeff Betcher, Veena Fauble, James L. Slack, Rochelle Chiffelle, Jane Olsen
Publikováno v:
Biology of Blood and Marrow Transplantation. (2):S229-S230
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffc12db332867e505ebb5b770fa96773
Autor:
Angela Toronjo Gómez
Publikováno v:
Gerokomos, Vol 17, Iss 2, Pp 13-14 (2006)
Externí odkaz:
https://doaj.org/article/fc18e1d51adf494eb13f58c3f839d787